Status:
WITHDRAWN
A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients.
Lead Sponsor:
Sutter Gould Medical Foundation
Conditions:
Anemia, Iron Deficiency
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to establish which dosing schedule of INfed (Iron dextrose) is superior for the treatment of iron deficient anemia.
Detailed Description
The purpose of this study is to establish which dosing schedule of INfed (Iron dextrose) is superior for the treatment of iron deficient anemia. The two dosing regimens under review are a low dose wee...
Eligibility Criteria
Inclusion
- Patients over the age of 18 years old.
- Being treated by a Sutter Health Physician.
- Hemoglobin of \< 10mg/dl for Men and Women
- Ferritin \</= 10ng/ml
- Patients in whom oral administration is unsatisfactory or impossible.
Exclusion
- Patients with a history of receiving iron or other hematinic in the preceding 3 months, oral iron is allowable.
- Anemia due to acute blood loss; menorrhagia is allowed.
- Patients with a current illness known to interact with iron status.
- Patients unwilling to consent to required blood draws.
- Patients who are viewed as unable to complete treatment, based on PI recommendation.
Key Trial Info
Start Date :
April 14 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03286205
Start Date
April 14 2015
End Date
August 31 2018
Last Update
June 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sutter Gould Medical Foundation
Modesto, California, United States, 95355